PubMed:26474493 / 1509-1747
Annnotations
GoldHamster
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T168 | 90-99 | GO:0023052 | denotes | signaling |
| T169 | 131-140 | MOP:0000569 | denotes | reduction |
| T170 | 187-194 | C413692 | denotes | nanogel |
| T171 | 187-194 | C413692 | denotes | nanogel |
| T173 | 195-202 | PR:000018264 | denotes | peptide |
| T175 | 195-202 | PR:000018263 | denotes | peptide |
| T172 | 195-202 | SO:0001064 | denotes | peptide |
| T174 | 195-202 | CHEBI:16670 | denotes | peptide |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 0-238 | DRI_Approach | denotes | Thus, nanomaterials targeting biological pathways, in our case interactions with integrin signaling, are a promising avenue toward reduction of CO. Further research is needed to optimize nanogel-peptide combinations that fully prevent CO. |
Goldhamster2_Cellosaurus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 105-106 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
| T11 | 144-146 | CVCL_J653|Cancer_cell_line|Homo sapiens | denotes | CO |
| T12 | 235-237 | CVCL_J653|Cancer_cell_line|Homo sapiens | denotes | CO |